Alliance for Clinical Trials in Oncology
- Research works
- 98 ▼ 18% vs 2013–17
- Citations
- 3.6k 36.6 per fractional work
- Top-10% rate
- 20.7% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Alliance for Clinical Trials in Oncology is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 5.0×. Every wedge is a field page.
- Health Professions 5.0×
- Medicine 3.1×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Economics, Econometrics and Finance 1.8×
- Pharmacology, Toxicology and Pharmaceutics 0.9×
- Mathematics 0.8×
- Psychology 0.7×
- Decision Sciences 0.6×
- Immunology and Microbiology 0.4×
- Social Sciences 0.3×
- Neuroscience 0.2×
- Computer Science 0.1×
- Business, Management and Accounting 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Arts and Humanities 0.1×
- Chemistry 0.1×
- Environmental Science 0.0×
Which keywords describe research at Alliance for Clinical Trials in Oncology?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Chemotherapy, Breast Cancer, Radiotherapy, Targeted Therapy, Quality of Life, Immunotherapy and Cancer.
- Radiotherapy
- Immunotherapy
- Breast Cancer
- Chemotherapy
- Clinical Trials
- Quality of Life
- Cancer
- Inflammation
- Targeted Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Clinical Trials2▲ 12×9 topics
- Chemotherapy2▲ 10×13 topics
- Quality of Life1▲ 4.0×10 topics
- Breast Cancer1▲ 22×8 topics
- Cancer1▲ 3.5×11 topics
- Immunotherapy1▲ 6.5×13 topics
- Inflammation1▲ 2.3×13 topics
- Radiotherapy1▲ 12×4 topics
- Targeted Therapy1▲ 19×4 topics
Which research topics does Alliance for Clinical Trials in Oncology publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 2 Cancer Genomics and Diagnostics Cancer Research 0 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 5 Breast Cancer Treatment Studies Cancer Research 0 works
- 6 Patient-Provider Communication in Healthcare General Health Professions 0 works
- 7 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
- 8 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 10 Cancer survivorship and care Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alliance for Clinical Trials in Oncology's research output changed?
Output in 2018–2022 was 18% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chicago
- University of Chicago
- University of Illinois Chicago
- Loyola University Chicago
- Rush University Medical Center
- Illinois Institute of Technology
- DePaul University
- Experimental Station
- Boeing (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.